COMPANY PROFILE · UPDATED 18 NOV 2025

TENTARIX BIOTHERAPEUTICS

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.

tentarix.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2020
Headcount: 40
Open roles: 0
Last raised: Series B · Sign in to view

LEADERSHIP

Founders & key people

Paul Kang

Founder at Tentarix Biotherapeutics

Tentarix Biotherapeutics

Michael Gallo

President at Innovative Targeting Solutions

Tentarix BiotherapeuticsInnovative Targeting SolutionsTentarix Biotherapeutics- Exclusive Strategic PartnerA2 BiotherapeuticsAmgenAbgenixStanford UniversityOhio State University

Paul Grayson

CEO at Bird Rock Bio

Versant VenturesBird Rock BioTentarix BiotherapeuticsAccessBioVenturesFate TherapeuticsSanderling VenturesUCIPaul Merage School of BusinessUCLA

Margaret Karow

Chief Officer at Tentarix Biotherapeutics

Tentarix BiotherapeuticsXilio TherapeuticsAkebia TherapeuticsAmgenRegeneron PharmaceuticalsUniversity of Utah School of MedicineUniversity of Colorado Boulder

Paul Kang

OPEN ROLES

Roles at TENTARIX BIOTHERAPEUTICS

Employbl doesn’t track TENTARIX BIOTHERAPEUTICS’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

FUNDING

Capital raised

Total raised

$93,000,000

Investors

Amplitude Ventures Gilead Sciences Samsara BioCapital Versant Ventures

Funding rounds

Series B
Diffbot knowledge graph
Amplitude Ventures, Samsara BioCapital, Versant Ventures, Gilead Sciences
$35MSep 5, 2023
Series A
Diffbot knowledge graph
Samsara BioCapital, Versant Ventures
$50MOct 13, 2021
Series Unknown
Diffbot knowledge graph
$8MSep 14, 2020